Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007
Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003
A Comparison of Lorazepam,Diazepam,and Placebo for the Treqatment of Out-of-Hospital Status Epilepticus
NEJM 345:631-637,689, Alldredge,B.K.,et al, 2001
Two New Drugs for Epilepsy
The Medical Letter, 42:33-35, , 2000
Zonisamide (Zonegran) for Epilepsy
The Medical Letter 42:94-95, , 2000
Practice Advisory:The Use of Felbamate in the Treatment of Patients with Intractable Epilepsy, Report of the quality Standards Subcommittee of the AAN and the American Epilepsy Society
Neurol 52:1540-1545, French,J.,et al, 1999
When to Start and Stop Anticonvulsant Therapy in Children
Arch Neurol 56:1073-1077, Greenwood,R.S.&Tennison,M.B., 1999
Parenteral Fosphenytoin:Efficacy and Economic Considerations
The Neurologist 4:S30-S34, Ramsay,R.E.&Wilder,B.J., 1998
Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
A Pharmacoeconomic Eval of IV Fosphenytoin (Cerebyx) vs IV Phenytoin (Dilantin) in Hosp ER Dept
Clin Therapeutics 18:953-966, Marchetti,A.,et al, 1996
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Drugs for Epilepsy
The Medical Letter, 37:37-401995., , 1995
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Evidence-Based Guideline Update: Vagus Nerve Stimulation for the Treatment of Epilepsy
Neurol 81:1453-1459, Morries, G.L.,et al, 2013
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
The SANAD Study of Effectiveness of Carbamazepine,Gabapentin,Lamotrigine,Oxcarbazepine,or Topiramate for Treatment of Partial Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1000-1015, Marson,A.G.,et al, 2007
Adult Epilepsy
Lancet 367:1087-1100, Duncan,J.S.,et al, 2006
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Epilepsy
NEJM 344:1145-1151, Browne,T.R. & Holmes,G.L., 2001
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000
Restrictions on the Availability of Antiepileptic Drugs
Arch Neurol 57:273-274,275, Bergen,D.C., 2000
Do New Antiepileptic Drugs Justify Their Expense
Arch Neurol 55:1140-1142, Chadwick,D., 1998
A Comparison of Rectal Diazepam Gell and Placebo for Acute Repetitive Seizures
NEJM 338:1869-1875, 19161998., Dreifuss,F.E.,et al, 1998
Treating Repetitive Seizures with a Rectal Diazepam Formulation,A Randomized Study
Neurol 51:1274-1282, Cereghino,J.J.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Long Term Use of Lamotrigine & Vigabatrin in Severe Refractory Epilepsy:Audit of Outcome
BMJ 313:1184-1185, 11571996., Walker,M.C.,et al, 1996
The Role of Epilepsy Centers in Delivering Care to Patients with Intractable Epilepsy
Neurol 44:1347-1352, Lesser,R.P., 1994
Epilepsy
JNNP 57:264-277, Chadwick,D., 1994
Update on Surgical Treatment of the Epilepsies, Second Intern Palm Desert Conf on Surgical Trtm of Epilepsies (1992)
Neurol 43:1612-1617, Engel,J.Jr., 1993
Neonatal Seizures
NEJM 388:1692-1700, Ropper.A.H., 2023
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus
Neurol 97:e564-e576, DeStefano, P.,et al, 2021
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary
Neurol 97:1072-1081, Gloss, D.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Cannabidiol in Patients with Seizures Associated with Lennox-Gastaut Syndrome (GWPCARE4): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
Lancet 391:1085-1096, Thiele, E.A.,et al, 2018
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
NEJM 378:1888-1897, Devinsky, O.,et al, 2018
Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
NEJM 376:2011-2020, Devinsky, O.,et al, 2017
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy
JAMA 313:285-293, Jobst, B.C. & Cascino, G.D., 2015
Epilepsy: New Advances
Lancet 385:884-898, Moshe, S.L.,et al, 2015
Anesthetic Drugs in Status Epilepticus: Risk or Rescue?
Neurol 82:656-664, Sutter, R.,et al, 2014